Veracyte (VCYT) Misses Q4 EPS by 3c

Go back to Veracyte (VCYT) Misses Q4 EPS by 3c

Veracyte (VCYT) PT Lowered to $11 at Leerink Partners

March 20, 2015 7:57 AM EDT

Leerink Partners analyst Dan Leonard maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT) but lowered his price target to $11.00 (from $14.00) following Q4 results.

Leonard commented, "VCYT's revenue for 4Q exceeded the Street and our expectations. While test volume growth is... More